OpenVSafe by OpenVAERS
Search V-safe

XVD-27754-54762

2 vaccinations 10 coded responses 14 check-ins 10 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
222 / VA
Registered
2021-09-30
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-08-27
    Dose 1 — Pfizer-BioNTech
  2. 2021-09-28
    Dose 2 — Pfizer-BioNTech
  3. 2021-09-30
    Registered in v-safe
  4. 2021-09-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-10-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest pain — Feeling: Poor · Site: Swelling, Itching · Fever · Headache, Muscle or body aches · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  6. 2021-10-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  7. 2021-10-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspnoea — Feeling: Good · Headache, Fatigue or tiredness
    MedDRA releases: 2024-11 · check-in answers available
  8. 2021-10-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  9. 2021-10-05
    Survey response — 7 day, dose 2
    MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2024-11 · check-in answers available
  10. 2021-10-05
    Report sent to call center — 7 day, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  11. 2021-10-12
    Survey response — 14 day, dose 2
    MedDRA: Heavy menstrual bleeding — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  12. 2021-10-19
    Survey response — 21 day, dose 2
    MedDRA: Muscle spasms — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  13. 2021-10-27
    Survey response — 28 day, dose 2
    MedDRA: Chest discomfort, Heart rate increased — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  14. 2021-11-02
    Survey response — 35 day, dose 2
    MedDRA: Memory impairment — Feeling: Good
    MedDRA releases: 2024-11 · check-in answers available
  15. 2021-11-09
    Survey response — 42 day, dose 2
    MedDRA: Hypoaesthesia, Joint lock, Neck pain, Pain, Self-medication — Feeling: Good · Be unable to work or attend school
    MedDRA releases: 2024-11 · check-in answers available
  16. 2021-11-22
    Call successful
    Participant prefers to complete VAERS report online
  17. 2021-12-28
    Survey response — 3 month, dose 2
    MedDRA: Hypoaesthesia — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  18. 2022-03-29
    Health check-in — 6 month, dose 2
    Feeling: Fair
    Adult check-in
  19. 2022-09-28
    Survey response — 12 month, dose 2
    MedDRA: Headache — Feeling: Fair · Be unable to work or attend school
    MedDRA releases: 2024-11 · check-in answers available

Vaccinations

DoseDateManufacturerCo-administered
12021-08-27Pfizer-BioNTech No
22021-09-28Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-10-05 Successful
2021-11-22
Participant prefers to complete VAERS report online

Free text

Release 9

Systemic reaction (other): Chest pains

Systemic reaction (other): Mild shortness of breathe

Release 10

Systemic reaction (other): Tested positive fir covid yesterday

Symptoms: Significantly heavier than my normal bleeding during menstrual cycle

Symptoms: Muscle spasms throughout body

Symptoms: Chest discomfort and high heart rate

Symptoms: Forgetfulness

Symptoms: My left arm locked up and a pain shot through my neck. My left hand went numb. I took aspirin for two days and it began to relax my arm and hand.

Symptoms: The sporadic numbness on left side of body

Release 12

Symptoms: Extreme headaches

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChest discomfort · · ✓
SDHeadache · · ✓
SDHeart rate increased · · ✓
SDHeavy menstrual bleeding · · ✓
SDHypoaesthesia · · ✓
SDJoint lock · · ✓
SDMemory impairment · · ✓
SDMuscle spasms · · ✓
SDNeck pain · · ✓
SDPain · · ✓
SDSelf-medication · · ✓
SROChest pain · · ✓
SRODyspnoea · · ✓
SROSARS-CoV-2 test positive · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release